Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
3-Indolepropionic acid to Homovanillic acid ratio	EFO_0021767	[Quantification of the ratio of 3-Indolepropionic acid to Homovanillic acid ratio in a sample.]
3-Indolepropionic acid to Lauric acid ratio	EFO_0021766	[Quantification of the ratio of 3-Indolepropionic acid to Lauric acid/Dodecanoic acid (C12:0) ratio in a sample.]
3-Indolepropionic acid to Myoinositol ratio	EFO_0021769	[Quantification of the ratio of 3-Indolepropionic acid to Myoinositol ratio in a sample.]
Pancreatic cysts	HP_0001737	[A cyst of the pancreas that possess a lining of mucous epithelium.]
N-acetyl-l-leucine to 3-Indolepropionic acid ratio	EFO_0021768	[Quantification of the ratio of N-acetyl-l-leucine to 3-Indolepropionic acid ratio in a sample.]
L-Phenylalanine to 3-Indolepropionic acid ratio	EFO_0021686	[Quantification of the ratio of L-Phenylalanine to 3-Indolepropionic acid ratio in a sample.]
3-Indolepropionic acid to L-Methionine ratio	EFO_0021685	[Quantification of the ratio of 3-Indolepropionic acid to L-Methionine ratio in a sample.]
3-Indolepropionic acid to Phenylpyruvic acid ratio	EFO_0021688	[Quantification of the ratio of 3-Indolepropionic acid to Phenylpyruvic acid ratio in a sample.]
3-Indolepropionic acid to L-Tyrosine ratio	EFO_0021687	[Quantification of the ratio of 3-Indolepropionic acid to L-Tyrosine ratio in a sample.]
3-Indolepropionic acid to L-Lysine ratio	EFO_0021682	[Quantification of the ratio of 3-Indolepropionic acid to L-Lysine ratio in a sample.]
L-Tryptophan to 3-Indolepropionic acid ratio	EFO_0021681	[Quantification of the ratio of L-Tryptophan to 3-Indolepropionic acid ratio in a sample.]
3-Indolepropionic acid to Adenine ratio	EFO_0021684	[Quantification of the ratio of 3-Indolepropionic acid to Adenine ratio in a sample.]
3-Indolepropionic acid to Uridine ratio	EFO_0021683	[Quantification of the ratio of 3-Indolepropionic acid to Uridine ratio in a sample.]
Cloverleaf skull - multiple congenital anomalies	Orphanet_93267	[This newly described syndrome is characterized by cloverleaf skull, limb anomalies, facial dysmorphism and multiple congenital anomalies.]
Cis-5,8,11,14,17-eicosapentaenoic acid (C20:5n3) to LysoPC 20:2 ratio	EFO_0021680	[Quantification of the ratio of Cis-5,8,11,14,17-eicosapentaenoic acid (C20:5n3) to LysoPC 20:2 ratio in a sample.]
Crouzon syndrome - acanthosis nigricans	Orphanet_93262	[Crouzon syndrome with acanthosis nigricans (CAN) is a very rare, clinically heterogeneous form of faciocraniostenosis with Crouzon-like features (see this term) with premature synostosis of cranial sutures associated with acanthosis nigricans.]
obsolete_Pfeiffer syndrome type 3	Orphanet_93260	[Pfeiffer syndrome type 3 (PS3) is a severe type of Pfeiffer syndrome characterized by bicoronal craniosynostosis, severe associated functional disorders, and hand, foot and elbow abnormalities.]
psoriasis vulgaris	EFO_1001494	[Plaque psoriasis is the most common presentation of psoriasis. It presents as small to large, well demarcated, red, scaly and thickened areas of skin. It most likely to affect elbows, knees, and lower back but may arise on any part of the body.]
cardiac embolism	EFO_1001493	[an embolism that is a result of an obstruction in a cardiac vessel due to a blood clot or other foreign matters]
atrophic macular degeneration	EFO_1001492	[Dry AMD is most common type of macular degeneration and affects 90% of the people who have the condition. In the dry form, there is a breakdown or thinning of the layer of retinal pigment epithelial cells (RPE) in the macula. No medical or surgical treatment is available for this condition.]